Massimo Dominici focuses on Mesenchymal stem cell, Stem cell, Stromal cell, Cell biology and Immunology. Massimo Dominici interconnects Cancer research, Neuroscience, Cell therapy and Cellular differentiation in the investigation of issues within Mesenchymal stem cell. The study incorporates disciplines such as Tumor necrosis factor alpha, Cytokine and Transfection in addition to Stem cell.
His work in Stromal cell addresses issues such as Regeneration, which are connected to fields such as Biologic response. His Immunology research includes themes of Clinical uses of mesenchymal stem cells, CD146, Regenerative medicine and Platelet-derived growth factor receptor. His research investigates the connection with Clinical uses of mesenchymal stem cells and areas like Multipotent Stem Cell which intersect with concerns in Dental pulp stem cells, Stem cell transplantation for articular cartilage repair, Musculoskeletal regeneration and Cord lining.
Massimo Dominici spends much of his time researching Mesenchymal stem cell, Stem cell, Cancer research, Immunology and Stromal cell. His Mesenchymal stem cell study combines topics in areas such as Progenitor cell, Regenerative medicine, Cell therapy and Bone marrow. His Stem cell research is within the category of Cell biology.
As a part of the same scientific study, Massimo Dominici usually deals with the Cancer research, concentrating on Cancer and frequently concerns with Lung cancer. His study in Transplantation extends to Immunology with its themes. The various areas that he examines in his Stromal cell study include Adipose tissue, Pancreatic cancer and CD90.
Massimo Dominici mainly investigates Internal medicine, Mesenchymal stem cell, Cancer research, Oncology and Cancer. His Mesenchymal stem cell study integrates concerns from other disciplines, such as Extracellular vesicles, Stromal cell and Regenerative medicine, Stem cell. His research in Stromal cell intersects with topics in Cell therapy, Pancreatic cancer and Drug.
His study on Cancer research also encompasses disciplines like
Progenitor cell which intersects with area such as Ewing's sarcoma,
Tumor microenvironment that intertwine with fields like Cell type. Massimo Dominici has researched Oncology in several fields, including Pathological, Patterns of care, Biliary cancer, Treatment outcome and Nivolumab. His Cancer study also includes fields such as
Lung cancer, which have a strong connection to Cancer stem cell, Precision medicine and Immunotherapy,
SOX2 which connect with Homeobox protein NANOG,
Lung that intertwine with fields like Pathology.
His main research concerns Mesenchymal stem cell, Cancer research, Stem cell, Stromal cell and Cancer. His Mesenchymal stem cell study is concerned with the larger field of Cell biology. His Cancer research research also works with subjects such as
His studies in Cell therapy integrate themes in fields like Immune system and Oncolytic virus. His work carried out in the field of Stem cell brings together such families of science as Metastasis, Pharmacodynamics and Transplantation. Massimo Dominici combines subjects such as Acquired diseases, Haematopoiesis, Pancreatic cancer, Progenitor cell and Adipose tissue with his study of Stromal cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
M. Dominici;K. Le Blanc;I. Mueller;I. Slaper-Cortenbach.
Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Clotilde Théry;Kenneth W. Witwer;Elena Aikawa;Maria Jose Alcaraz.
Journal of extracellular vesicles (2018)
Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement
E.M. Horwitz;K. Le Blanc;M. Dominici;I. Mueller.
Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Philippe Bourin;Bruce A. Bunnell;Louis Casteilla;Massimo Dominici.
Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs
Caridad Martinez;Ted J. Hofmann;Roberta Marino;Roberta Marino;Massimo Dominici.
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi.
Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.
Ingo Müller;S. Kordowich;C. Holzwarth;C. Spano.
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
Giulia Grisendi;Rita Bussolari;Luigi Cafarelli;Istvan Petak.
Cancer Research (2010)
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells.
Friederike Gieseke;Judith Böhringer;Rita Bussolari;Massimo Dominici.
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
Olivia Candini;Giulia Grisendi;Elisabetta Manuela Foppiani;Matteo Brogli.
Scientific Reports (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: